Skip to main content
Phillip Kuo, MD, Nuclear Medicine, Hamden, CT, Banner - University Medical Center Tucson

PhillipHsinKuoMD

Nuclear Medicine Hamden, CT

Physician

Are you Dr. Kuo?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 79 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Phillip Kuo, MD is a board certified nuclear medicine physician in Hamden, Connecticut. He is currently licensed to practice medicine in Connecticut, Arizona, and California. He is affiliated with Banner - University Medical Center Tucson, Tucson VA Medical Center, and Banner - University Medical Center South.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Radiology-Diagnostic, 2005 - 2008
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2000 - 2003
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 2000

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - Present
  • AZ State Medical License
    AZ State Medical License 2009 - 2025
  • CT State Medical License
    CT State Medical License 2003 - 2010
  • American Board of Nuclear Medicine Nuclear Medicine
  • American Board of Radiology Diagnostic Radiology
  • American Board of Radiology Nuclear Radiology

Awards, Honors, & Recognition

  • Top Doctors:Arizona State Castle Connolly, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Radionuclides That Target and Kill Advanced Prostate Cancer Cells Show Great Promise
    Radionuclides That Target and Kill Advanced Prostate Cancer Cells Show Great PromiseSeptember 20th, 2022
  • Imaging Criteria Helps Pick Best Patients for Pluvicto Treatment
    Imaging Criteria Helps Pick Best Patients for Pluvicto TreatmentMay 3rd, 2022
  • Blue Earth Diagnostics Announces Publication of Post-Hoc Analysis Evaluating Impact of Urinary Activity on Image Interpretation of POSLUMA® (Flotufolastat F 18) PET in Prostate Cancer
    Blue Earth Diagnostics Announces Publication of Post-Hoc Analysis Evaluating Impact of Urinary Activity on Image Interpretation of POSLUMA® (Flotufolastat F 18) PET in Prostate CancerDecember 2nd, 2023
  • Join now to see all

Hospital Affiliations